FDA Approves First Oral Blood Thinning Medication for Children

Today, the FDA approved Pradaxa oral pellets and capsules to treat children with blood clots directly after they have been treated with a blood thinner given by injection for at least five days, and to prevent recurrent clots among patients who completed treatment for their first clot.

Original source: http://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-blood-thinning-medication-children

Related Posts